Introduction {#Sec1}
============

Tracheostomy placement is a medical intervention often used for those with complex respiratory conditions \[[@CR1]--[@CR3]\]. These artificial airways provide direct, unobstructed lower respiratory tract access to maximize ventilation \[[@CR4]--[@CR7]\], expedite oxygen entry, and facilitate secretion management \[[@CR6], [@CR7]\]. Given the anatomical location of a tracheostomy and the shared pathway of the respiratory and alimentary systems, the tracheostomy may have unintended, even adverse consequences. Despite their benefits, it is often debated whether tracheostomies increase the risk of upper airway complications \[[@CR2], [@CR8], [@CR9]\]. One such complication is dysphagia (swallowing impairment) \[[@CR10], [@CR11]\].

Dysphagia occurs in 11% to 93% of patients following tracheostomy \[[@CR10], [@CR12], [@CR13]\]. Dysphagia, if unmanaged, can lead to adverse medical outcomes including respiratory complications, nutritional compromise, and even death \[[@CR14]--[@CR16]\]. Swallowing is a complex sensorimotor process \[[@CR17]\] which, when functioning optimally, ensures safe passage of the oral bolus into the lower deglutitive tract. Disruption to the upper airway by way of a tracheostomy may lead to physiological and/or biomechanical changes to the swallow, thereby increasing dysphagia risk \[[@CR9], [@CR18]\]. There are several posited explanations as to why dysphagia occurs in these patients, including reduced sensory input, laryngeal structure disuse atrophy, and subglottic air pressure reduction. In an effort to wean the patients from the artificial airway, tracheostomy modifications are often employed as management strategies \[[@CR19]\].

Tracheostomy weaning is a complex process that is often directed by patients' pulmonary function and overall medical status. Among many factors, determinants that precede tracheostomy weaning may include improved respiratory and/or ventilator capability, secretion management, cough effectiveness, and level of consciousness \[[@CR20], [@CR21]\]. Various management strategies to assist with tracheostomy weaning are available to clinicians. These often include cannula size reduction, fenestration, cuff pressure reduction (deflation), and/or partial or total occlusion of the artificial airway \[[@CR3], [@CR18]\]. Often when these methods are employed, improvements in swallowing physiology have been reported \[[@CR22]\] particularly with secretion clearance, cough, and airway protection \[[@CR23]--[@CR25]\]. The true reason behind these changes have been debated given the multifactorial nature of the patient's condition. For example, some attribute these swallowing improvements to the overall improvement of the patient's health rather than due to the tracheostomy modification itself \[[@CR11], [@CR26], [@CR27]\]. While tracheostomy modifications are widely employed to assist with weaning, consensus on whether they improve swallow physiology has yet to be reached. As a result, we conducted a systematic review in order to evaluate and synthesize the available evidence on swallow physiology following tracheostomy modification in adults.

Materials and Methods {#Sec2}
=====================

Ethical Considerations {#Sec3}
----------------------

We conducted a systematic review to describe the effect of tracheostomy modifications on swallow physiology and/or swallowing-related outcomes. Our methodology was adapted from the Cochrane Handbook \[[@CR28]\], following the Collaboration's conventions, and was registered a priori (available here: <https://www.crd.york.ac.uk/PROSPERO/>).

Operational Definitions {#Sec4}
-----------------------

We operationalized relevant terms to this systematic review a priori. D*ysphagia* (*disordered swallowing*) was defined as any oral or pharyngeal swallowing abnormality \[[@CR29]\] determined by an instrumental swallowing assessment. Swallowing instrumentation included, but was not limited to, videofluoroscopic swallow study (VFSS) or fiberoptic endoscopic evaluation of swallowing (FEES). We defined *aspiration* as the entry of ingested material below the level of the vocal folds \[[@CR30]\]. For terms related to the artificial airway, we defined *tracheotomy* as a surgical opening in the trachea \[[@CR6], [@CR31]\], whereas *tracheostomy* is the temporary maintenance of that opening by virtue of a tracheostomy tube placement \[[@CR6], [@CR31]\]. *Tracheostomy modifications* included alterations to one or more of the following: (1) tracheostomy tube dimension, material and/or fenestration, (2) cuff status, and/or (3) occlusion status (including but not limited to digital occlusion or one-way speaking valve placement). The *tracheostomy cuff* (if present) was the inflatable band located on the distal cannula with *cuff status* referring to inflation (cuff up) or deflation (cuff down) \[[@CR4], [@CR6]\]. During our analyses, we defined functional swallowing improvement as facilitative changes to swallowing parameters leading to a safer or more efficient swallow.

Search Strategy {#Sec5}
---------------

From the beginning of online availability to May 2017 (inclusive), we searched for eligible studies in eight electronic databases: Allied and Complementary Medicine Database (AMED), Biosciences Information Service (BIOSIS Previews), Cumulative Index to Nursing & Allied Health Literature (CINAHL), Excerpta Medica Database (Embase), Evidence Based Medicine Reviews, Healthstar, MEDLINE and PsycInfo. We manually searched for citations in 11 journals: Archives of Surgery, Canadian Journal of Surgery, Chest, Critical Care Medicine, Dysphagia, Head & Neck, Intensive Care Medicine, International Journal of Speech Pathology, Journal of Otolaryngology, Laryngoscope, and the Head & Neck Journal. Our searches also included nine grey literature repositories: Canadian Agency for Drugs and Technologies in Health (CADTH), Centers for Disease Control and Prevention, National Health Service, Proquest Dissertations, Theses Canada Portal, Canadian Best Practices Portal, National Guideline Clearinghouse, Canadian Medical Association (CMA Infobase), and Clinical Practice Guidelines. Using the accepted English articles, we performed forward and backward citation chasing \[[@CR32]\]. Specifically, we reviewed study titles citing the accepted articles for possible inclusion as well as their respective reference lists \[[@CR32]\]. We then applied our eligibility criteria to these citations. We iterated this process on the new articles. A health sciences research librarian designed our search strategy, which was subsequently peer reviewed by an independent information scientist. Our searches included key terms germane to our study objective, including "tracheotomy" or "tracheostomy" or "trach\*" and "dysphagia", "swallow\*", "swallowing disorders", and "deglutition". A detailed search strategy summary may be requested from the authors.

Eligibility Criteria {#Sec6}
--------------------

Articles that reported on oropharyngeal dysphagia as identified by instrumentation in adults (aged 17 years and older) who underwent tracheostomy placement were included. To meet our criteria, the primary study design had to report on these swallowing outcomes following the tracheostomy modification(s). We accepted case series studies (*n* \> 10), prospective or retrospective observational studies, and randomized control trials published in any language. Studies with pediatric enrollees were excluded. In addition, we excluded patients who were diagnosed with head and neck cancer and/or neurodegenerative diseases (including Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease and/or muscular dystrophies and/or atrophies). If a study had portions of their patient sample meeting our inclusion criteria, however their outcomes were not extractable, we contacted the authors in order to request germane patient-level data for possible inclusion. Studies that solely included patient dysphagia symptom reporting or clinical bedside exams were also excluded.

Study Selection {#Sec7}
---------------

Two authors blinded to each other's judgments screened all citations and abstracts for possible inclusion (LW and SAS). If inclusion could not be determined by reviewing the abstract, the citation was accepted and its full text reviewed. Full text was retrieved for all accepted abstracts. Two authors (NA and SAS) blinded to each other's judgments reviewed full study texts to determine eligibility for final inclusion. Throughout the review process, we used a study selection form designed a priori and eligibility disagreements were resolved by consensus.

Methodological Quality Assessment {#Sec8}
---------------------------------

Two raters (NA and AE) blinded to each other's judgments assessed study quality using the Cochrane risk of bias tool \[[@CR28]\]. Domains included random sequence generation and allocation concealment (as applicable), blinding, incomplete outcome reporting, attrition, and selective outcome reporting. We adapted the risk of bias to include other domains pertinent to our study including operational definitions for tracheostomy conditions and swallowing outcomes, patient sampling, consistent assessment across enrollees, and baseline measures. We resolved all disagreements by consensus; however, if consensus was not reached, a third rater (SAS) rendered the final decision.

Data Extraction {#Sec9}
---------------

We used a form designed a priori. One author (NA) extracted data regarding study design, sample size, patient diagnoses and characteristics, tracheostomy details, swallowing assessment method(s), and outcomes. A second reviewer (AE) checked all extracted data for accuracy. Missing and/or pertinent patient-level data were requested from primary study authors. Due to the heterogeneity of patient diagnosis, study methods, and study outcomes, we did not complete a meta-analysis.

Results {#Sec10}
=======

Literature Retrieved {#Sec11}
--------------------

We retrieved 7079 citations through database and manual searching (Fig. [1](#Fig1){ref-type="fig"}). Of these, 1461 were without an abstract and eliminated. We reviewed the remaining 5618 titles and abstracts, eliminating an additional 4979 citations, as they did not meet inclusion criteria. We retrieved and reviewed 639 full texts. Of these, 13 languages were represented, including English. Following full text review, we rejected 629 articles not meeting our inclusion criteria. Specifically, 595 did not include tracheostomy modifications, 28 were eliminated as they included patients with primary diagnoses of head and neck cancer and/or neurodegenerative disease, and two had sample sizes smaller than 10. Other study eliminations included three that did not assess swallowing using methods meeting our inclusion criteria \[[@CR33]--[@CR35]\], and one that included patients younger than seventeen years \[[@CR30]\]. Six studies had portions of their patient sample meeting our inclusion criteria; however, they were excluded following author contact as the pertinent outcomes were not extractable \[[@CR19], [@CR30], [@CR33], [@CR36]--[@CR38]\]. A total of 10 articles were accepted for analysis \[[@CR39]--[@CR47]\] (Table [1](#Tab1){ref-type="table"}).Fig. 1Study selection processTable 1Study characteristicsStudyYearCountryStudy design*N*Age (y)\
Mean (SD)\*Patient diagnosesTracheostomy manipulationSwallow outcomesInstrumentationMeasuresAmathieu et al. \[[@CR41]\]2012FranceCase series1237.0Trauma^a^Cuff^b^EMG and accelerometryQuantitativeDavis et al. \[[@CR46]\]2002USACase series1260.0Medical, respiratory^c^Cuff^d^VFSSImpairmentElpern et al. \[[@CR48]\]2000USACase series1560.1 (14.4)Cardiothoracic, medical, neurogenic, trauma, respiratory^e^Valve^f^VFSSImpairmentDonzelli et al. \[[@CR42]\]2006USATCase series4062.8 (12.0)Medical, neurogenic, respiratory^g^Occlusion^h^FEESImpairmentLeder \[[@CR39]\]1999USACase series20^‡^68.0 (13.0)Cardiothoracic, medical, neurogenic, surgical, trauma, respiratory^i^Valve^f^FEESImpairmentLeder et al. \[[@CR40]\]2001USACase series1164.3 (15.4)Medical, respiratory^j^Occlusion^k^ManometryQuantitativeLeder et al. \[[@CR43]\]1996USACase series1961.0 (21.0)Cardiothoracic, medical, neurogenic, respiratory^l^Occlusion^m^VFSSImpairmentLedl and Ullrich \[[@CR45]\]2017GermanyCase series2061.5 (12.8)Neurogenic^n^Occlusion^m^FEES and manometryImpairment; quantitativeOhmae et al. \[[@CR47]\]2006JapanCase series1667.3 (13.0)Respiratory, medical, cardiothoracic^o^Valve^f^FEES and VFSSImpairment; quantitativeSuiter et al. \[[@CR44]\]2003USACase series1819--80 (range)Cardiothoracic, neurogenic, respiratory^p^Cuff, valve^q^VFSSImpairment; quantitative*ARDS* acute respiratory distress syndrome; *CABG* coronary artery bypass graft surgery; *CHF* congestive heart failure; *COPD* chronic obstructive pulmonary disease; *CVA* cerebral vascular accident; *EMG* electromyography; *FEES* fiberoptic endoscopic evaluation of swallowing; *MVA* motor vehicle accident; *N* patients who meet inclusion criteria for this review; *PNA* pneumonia; *SD* standard deviation; *VFSS* videofluoroscopic swallowing study; *y* year^a^Thoracic/abdominal. ^b^Cuff pressure variations: 5, 10, 15, 20, 25, 30, 40, 50, and 60 cm H~2~O. ^c^Multi-organ failure, sepsis, ARDS, pneumonia. ^d^Inflation/deflation comparison. ^e^Multiple trauma, CABG, CVA, CHF, PNA, lung cancer, smoke inhalation, COPD. ^f^ ± one-way speaking valve. ^g^Heart failure, CVA, traumatic brain injury, spinal cord injury, respiratory failure. ^h^Digital occlusion, one-way speaking valve, cap. ^i^Thoracic aortic aneurysm, post-operative CVA, adult-onset diabetes, perforated duodenal ulcer repair, MVA, cancer, CVA, nephrectomy, hemicolectomy, esophagectomy, bowel resection, incarcerated hernia repair, ARDS, Legionnaire's disease, respiratory failure. ^j^CHF, subglottic stenosis, abdominal aortic aneurysm, cardiac arrest, PNA, COPD, ARDS. ^k^ ± digital occlusion. ^l^Coronary artery disease, colon cancer, necrotic left lung, human immunodeficiency virus, MVA, liver cirrhosis, cancer, assault/multiple facial and non-facial trauma, quadriplegia, CVA, PNA, ARDS, COPD, cardio-pulmonary disease. ^m^ ± occlusion (method unspecified). ^n^CVA. ^o^Respiratory failure, pharyngeal edema, heart failure. ^p^CABG, abdominal aortic aneurysm repair, closed head injury, COPD, ARDS. ^q^Cuff inflation vs. deflation, cuff inflation vs. one-way speaking valve, cuff deflation vs. one-way speaking valve^\*^Unless otherwise stated^‡^13 patients did not receive FEES following speaking valve removal therefore this FEES data not included herein

Study Characteristics and Methodological Quality Assessment {#Sec12}
-----------------------------------------------------------

Of the 10 accepted articles (Table [1](#Tab1){ref-type="table"}), all were prospective case series \[[@CR39]--[@CR47]\]. Study sample sizes ranged from 11 \[[@CR40]\] to 40 \[[@CR42]\] patients and included heterogeneous diagnoses in all but two studies \[[@CR41], [@CR45]\]. Nine of the included studies \[[@CR39]--[@CR46], [@CR48]\] were published in English and one was published in Japanese \[[@CR47]\].

We assessed study quality using the Cochrane Collaboration's risk of bias tool \[[@CR28]\] (Table [2](#Tab2){ref-type="table"}). Four studies \[[@CR42], [@CR45], [@CR46], [@CR48]\] declared their patient selection/sampling methods with six \[[@CR40], [@CR41], [@CR45]--[@CR48]\] declaring their inclusion and exclusion criteria. Of the 10 studies, two \[[@CR43], [@CR46]\] declared blinding of outcome assessors; however, none reported on patient blinding. Nine studies \[[@CR39]--[@CR42], [@CR44]--[@CR48]\] had no missing outcome data and six studies \[[@CR40]--[@CR42], [@CR45]--[@CR47]\] did not have selective outcome reporting. All 10 \[[@CR39]--[@CR48]\] operationally defined their outcome measures with seven studies \[[@CR39]--[@CR41], [@CR43]--[@CR45], [@CR47]\] using operational definitions for tracheostomy conditions/modifications. Eight studies \[[@CR40]--[@CR46], [@CR48]\] maintained consistent assessment across all patients and of those, four \[[@CR39]--[@CR41], [@CR43]\] reported patients' baseline measures. Due to study design, no study incorporated sequence generation or allocation concealment.Table 2Risk of bias across studiesStudySequence generationAllocation concealmentPatient sampling descriptionInclusion/exclusion criteriaAssessor blindingAttrition justifiedAll outcomes addressedSelective outcome reportingOutcomes operationally definedTracheostomy conditions operationally definedConsistent assessment for enrolleesBaseline measuresAmathieu et al. \[[@CR41]\]N/AN/ANoYesUnclearYesYesNoYesYesYesYesDavis et al. \[[@CR46]\]N/AN/AYesYesYesYesYesNoYesNoYesNoDonzelli et al. \[[@CR42]\]N/AN/AYesNoUnclearYesYesNoYesNoYesNoElpern et al. \[[@CR48]\]N/AN/AYesYesUnclearYesYesYesYesYesYesN/ALeder \[[@CR39]\]N/AN/ANoNoUnclearYesYesYesYesYesNoYesLeder et al. \[[@CR43]\]N/AN/ANoNoYesYesNoYesYesYesYesYesLeder et al. \[[@CR40]\]N/AN/ANoYesUnclearYesYesNoYesYesYesYesLedl and Ullrich \[[@CR45]\]N/AN/AYesYesUnclearYesYesNoYesYesYesNoOhmae et al. \[[@CR47]\]N/AN/ANoYesUnclearYesYesNoYesYesNoNoSuiter et al. \[[@CR44]\]N/AN/ANoNoUnclearYesYesYesYesYesYesNo*N/A* not applicable

Tracheostomy Modifications and Swallowing Outcomes {#Sec13}
--------------------------------------------------

Our included studies utilized a wide range of tracheostomy modifications: three studies altered cuff status \[[@CR41], [@CR44], [@CR46]\], four used varying degrees of tracheostomy tube occlusion \[[@CR40], [@CR42], [@CR43], [@CR45]\], and four compared one-way speaking valve conditions \[[@CR39], [@CR44], [@CR47], [@CR48]\] (Table [1](#Tab1){ref-type="table"}). Of those examining cuff alterations \[[@CR41], [@CR44], [@CR46]\], one \[[@CR41]\] examined cuff inflation at various air pressures and two \[[@CR44], [@CR46]\] compared cuff inflation and deflation. Four studies \[[@CR40], [@CR42], [@CR43], [@CR45]\] examined varying degrees of occlusion specifically: (1) one \[[@CR40]\] compared digital occlusion to an open tracheostomy, (2) one \[[@CR42]\] compared digital, speaking valve, and capped occlusion, and (3) two \[[@CR43], [@CR45]\] reported on "open" and "closed" conditions. Of the four studies \[[@CR39], [@CR44], [@CR47], [@CR48]\] comparing one-way speaking valve conditions, three \[[@CR39], [@CR47], [@CR48]\] compared outcomes following valve placement and/or removal, and one \[[@CR44]\] compared mixed conditions (cuff inflation and/or deflation condition versus valve placement). Across studies, one reported on baseline pulmonary performance (e.g. respiratory rate, arterial oxygen saturation, cough capability) at the time of the modification \[[@CR41]\]. Two reported on tracheostomy tube diameter \[[@CR44], [@CR48]\] and six described tracheostomy tube types \[[@CR40], [@CR42]--[@CR45], [@CR48]\].

Studies measured swallowing outcomes by way of impairment descriptions \[[@CR39], [@CR42]--[@CR48]\] (Table [3](#Tab3){ref-type="table"}) or through quantitative measurements \[[@CR40], [@CR41], [@CR44], [@CR45], [@CR47]\] (Table [4](#Tab4){ref-type="table"}). For those studies describing impairment \[[@CR39], [@CR42]--[@CR48]\], swallowing was assessed using videofluoroscopy (VFSS) \[[@CR43], [@CR44], [@CR46]--[@CR48]\] and/or fiberoptic endoscopic evaluation of swallowing (FEES) \[[@CR39], [@CR42], [@CR45], [@CR47]\]. When characterizing the impairment, studies utilized psychometrically validated scales \[[@CR44], [@CR45]\], descriptive methods including binary (presence/absence) of a physiological event \[[@CR39], [@CR42], [@CR43], [@CR47], [@CR48]\], or study-specific scales \[[@CR44], [@CR46], [@CR47]\]. Impairments included descriptions of aspiration only \[[@CR39], [@CR42], [@CR43], [@CR46], [@CR48]\], both aspiration and penetration \[[@CR44], [@CR45], [@CR47]\], and residue \[[@CR44], [@CR47]\]. For those studies conducting quantitative measurements \[[@CR40], [@CR41], [@CR44], [@CR45], [@CR47]\], one study used electromyography (EMG) \[[@CR41]\], one used accelerometry \[[@CR41]\], two used manometry \[[@CR40], [@CR45]\], and two used VFSS \[[@CR44], [@CR47]\]. Three studies \[[@CR41], [@CR44], [@CR47]\] reported on swallow duration times. Of these, two \[[@CR41], [@CR47]\] examined swallowing reflex time and one \[[@CR44]\] assessed pharyngeal transit time and cricopharyngeal opening duration. Other parameters included hyolaryngeal movement \[[@CR41], [@CR44], [@CR47]\] and submental muscle activation \[[@CR41]\]. Two studies \[[@CR40], [@CR45]\] reported pressure measures including: oropharyngeal \[[@CR45]\], pharyngeal \[[@CR40]\], hypopharyngeal \[[@CR45]\], and upper esophageal \[[@CR40], [@CR45]\]. One study \[[@CR45]\] measured oropharyngeal and hypopharyngeal pressure durations as well as upper esophageal sphincter pressure relaxation.Table 3Swallowing impairment and scale type according to tracheostomy modificationsStudyAirwayOutcomesTT duration\
(range, d)TT modification\
duration, mean (SD)Condition comparisonImpairmentRating scaleFunctional improvement^‡^*Cuff*Davis et al. \[[@CR46]\]\*\*NRNRInfl vs. deflAsp5-pt scale^a^Y^b^Suiter et al. \[[@CR44]\]5--29Worn at least onceInfl vs. deflPAPASNRes3-pt scale^c^N*Cuff and valve*Suiter et al. \[[@CR44]\]5--29Worn at least onceInfl vs. + SVPAPASYRes3-pt scale^c^N^d^Defl/cuffless vs. + SVPAPASY^e^Res3-pt scale^c^N*Valve*Elpern et al. \[[@CR48]\]13--58Variable^f^ − SV vs. + SVAsp ± Y^g^PenLeder \[[@CR39]\]4--493.9 (1.4) − SV vs. + SVAsp ± Y^h^Ohmae et al. \[[@CR47]\]30--90+ NR − SV vs. + SVAsp ± NPen ± YRes^i^3-pt scaleYRes^j^3-pt scaleN*Occlusion*Donzelli et al. \[[@CR42]\]NRNRDigital occl vs. + SV vs. cappedAsp ± Y^k^Secretion level5-pt scale^l^YLeder et al. \[[@CR43]\]\*\*8--546NRUnoccl vs. occlAsp ± N^m^Ledl and Ullrich \[[@CR45]\]58.0 (mean); 34.1 (SD)Cuff deflation: 8.0 (7.0) hours/dCapped: 4.9 (5.3) hours/dUnoccl vs. occlPAPASY*Asp* aspiration, *d* days, *defl* cuff deflation, *infl* cuff inflation, *N* no, *NR* not reported, *NS* non-significant findings reported, but no p-value provided, *occl* occlusion, *PA* penetration and aspiration, *PAS* Penetration--aspiration Scale \[[@CR49]\], *Pen* penetration, *pt* point, *Res* residue, *SD* standard deviation, *SV* speaking valve, *TT* tracheostomy tube, *unoccl* unocclusion, *y* year, *Y* yes^a^Grading Scale: 0 = no aspiration, 1 = aspiration of less than 10% accompanied by cough, choking, or distress, 2 = aspiration of less than 10% without cough, 3 = aspiration of more than 10% with cough, 4 = aspiration of more than 10% without cough. ^b^Cuff status and bolus type were significant aspiration predictors. ^c^3-point scale: 0 = no residue, 1 = coating, 2 = pooling. ^d^Residue was greater with + SV. ^e^For thin liquid boluses only. ^f^Twelve subjects had intermittent use of Passy-Muir speaking valve, ranging from 2--6 weeks. ^g^Reduced aspiration with PMV on, *p* = 0.016. ^h^No aspiration after initial SV placement in 7/20 previously aspirating patients, not statistically tested. ^i^Laryngeal residue. ^j^Pharyngeal residue. ^k^Aspiration rates reduced however occlusion type and aspiration rate relation not statistically significant. ^l^Marianjoy 5-point secretion scale. ^m^Not statistically tested^\*^Unless otherwise specified, \*\*data meeting inclusion criteria, ^‡^comparison statistically significant unless otherwise specified, + presence, − absenceTable 4Quantitative measures according to tracheostomy modificationsStudyAirwayOutcomesTT duration\
(range, d)TT condition\
duration (d)Study comparisonParameterMeasurementFunctional improvement\*\**Cuff*Amathieu et al. \[[@CR41]\]NRNRInfl vs. deflSubmental muscle activityEMGpYLaryngeal accelerationALAYSwallow latency timemsYSuiter et al. \[[@CR44]\]5- to- 29Worn at least onceInfl vs. deflSwallow durations^a^msYPharyngeal transit durationN^b^Anterior hyoid excursion durationY^b^Cricopharyngeal opening durationY^c^Laryngeal elevationmmNAnterior hyoid excursionY*Cuff and valve*Suiter et al. \[[@CR44]\]5-to-29Worn at least onceInfl vs. + SVSwallow duration^d^msNLaryngeal elevationmmNAnterior hyoid excursionNDefl/cuffless vs. + SVSwallow duration^d^msNLaryngeal elevationmmNAnterior hyoid excursionN*Speaking valve*Ohmae et al. \[[@CR47]\]30--90+ NR-SV vs. + SVLaryngeal elevationNRNSwallow reflexNRN*Occlusion*Leder et al. \[[@CR40]\]6d--5.5yNRUnoccl vs. occlPharyngeal pressure^e^mmHgNUES pressure^e^NLedl et al. \[[@CR45]\]58.0 (mean); 34.1 (SD)Cuff deflation: 8.0 (7.0) hours/dCapped: 4.9 (5.3) hours/dUnoccl vs. occlOropharyngeal pressuremmHgNHypopharyngeal pressureNUES relaxationNOropharyngeal pressure durationsecNHypopharyngeal pressure durationNUES relaxation durationN*ALA* amplitude of laryngeal acceleration, *defl* cuff deflation, *EMGp* peak electromyographic activity, *infl* cuff inflation, *mm* millimeters, *mmHg* millimeter of mercury, *ms* milliseconds, *N* no, *NR* not reported, *NS* non-significant findings reported and no p-value provided, *occl* occlusion, *sec* seconds, *SV* speaking valve, *UES* upper esophageal sphincter, *unoccl* unocclusion, *y* year, *Y* yes^a^Swallow duration measures (oral transit, stage transition, and total swallow) not reported individually. ^b^Longer duration with deflated condition. ^c^Shorter duration with deflated condition. ^d^Means and p-values for individual swallow duration measures (oral transition, stage transition, pharyngeal transit, maximum hyoid, maximum anterior excursion, cricopharyngeal opening, and total swallow) were not reported. ^e^Outcomes pertain to all patients (n = 11), non-aspirating patients (n = 7), and aspirating patients (n = 4)^\*^Unless otherwise specified; \*\*comparison statistically significant unless otherwise stated; \> greater than; + , presence

### Tracheostomy Modifications and Swallow Impairment {#Sec14}

The effects of tracheostomy modifications on swallowing impairment varied across studies (Table [3](#Tab3){ref-type="table"}, Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). When comparing cuff modifications, two studies \[[@CR44], [@CR46]\] found that cuff deflation did not yield significant changes to the rates of aspiration \[[@CR46]\], aspiration--penetration \[[@CR44]\], or residue \[[@CR44]\]. In contrast, one study reported that cuff status was a significant predictor of aspiration \[[@CR46]\]. In the single study that compared cuff inflation to a one-way speaking valve condition \[[@CR44]\], penetration--aspiration scores lowered significantly in the valve condition, but greater residue was measured in the oral cavity, on the pharyngeal wall, and along the cricopharyngeus across all bolus textures. In the same study, when comparing cuff deflation or a cuffless tracheostomy tube to the valve, significantly lower penetration--aspiration scores were reported in the valve condition for liquid boluses, without a significant effect on residue.Fig. 2Swallowing impairment according to tracheostomy tube modifications. *DO* digital occlusion, *Infl* cuff inflation, *NR* not reported, *NT* not tested statistically, *SV* speaking valve, *Unoccl* unoccluded, *Occl* occluded; ( +) = with; ( −) = withoutFig. 3Penetration--aspiration scores according to tracheostomy tube modifications. ( +) Inflation vs. ( +) SV condition significant (*p* = 0.01). *Infl* cuff inflation, *NR* not reported, *SV* speaking valve, ( +) = with, ( −) = without

A total of six studies compared various methods of tracheostomy occlusion while assessing their effect on swallowing impairment \[[@CR39], [@CR42], [@CR43], [@CR45], [@CR47], [@CR48]\] (Table [3](#Tab3){ref-type="table"}, Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). Of these, three studies \[[@CR42], [@CR43], [@CR45]\] utilized digital occlusion, speaking valve, tracheostomy capping, or an unspecified occlusion method and yielded equivocal results. One study \[[@CR45]\] found significantly lower aspiration--penetration rates in an occluded condition (unspecified), whereas another study \[[@CR43]\] reported that aspiration rates remained unchanged regardless of occlusion. In the third study \[[@CR42]\], aspiration rates decreased across three occlusion conditions (i.e. digital occlusion, speaking valve, tracheostomy cap); however, the differences between occlusion type and their respective aspiration rates were not statistically significant. Three studies \[[@CR39], [@CR47], [@CR48]\] compared a speaking valve condition to no occlusion. Two \[[@CR41], [@CR48]\] reported aspiration rates reduced after valve placement though this was only tested statistically in one study \[[@CR48]\]. While the third study \[[@CR47]\] reported valve placement had no significant effect on aspiration, the authors did find valve placement significantly reduced penetration rates and residue.

### Tracheostomy Modifications and Quantitative Measures {#Sec15}

Of the two studies conducting quantitative swallowing measurements following alterations to cuff inflation \[[@CR41], [@CR44]\], both reported changes in most \[[@CR44]\] if not all \[[@CR41]\] parameters (Table [4](#Tab4){ref-type="table"}). Specific findings included: increasing cuff pressure \[[@CR41]\] delayed swallow initiation while decreasing laryngeal elevation and submental muscle amplitude and cuff deflation \[[@CR44]\] significantly increased some duration measures (i.e. pharyngeal transit time, anterior hyoid excursion duration) while shortening cricopharyngeal opening duration. Both studies \[[@CR41], [@CR44]\] reported that cuff deflation resulted in significantly greater anterior hyoid excursion. Tracheostomy occlusion, whether it was valve placement \[[@CR44], [@CR47]\] or an open versus closed tracheostomy condition \[[@CR40], [@CR45]\] did not change quantitative measurements significantly (Table [4](#Tab4){ref-type="table"}, Fig. [4](#Fig4){ref-type="fig"}).Fig. 4Quantitative measures according to tracheostomy tube occlusion. *mmHG* millimeter of mercury, *NS* not significant, *UES* upper esophageal sphincter

Discussion {#Sec16}
==========

Summary of Main Results {#Sec17}
-----------------------

This systematic review confirms that when comparing tracheostomy modification conditions, swallowing outcomes are highly variable. Our review included 10 studies \[[@CR39]--[@CR48]\] that compared a variety of tracheostomy modifications, including (1) cuff alterations (cuff presence and/or absence and/or inflation and/or deflation), (2) occlusion methods (digital occlusion and/or one-way speaking valve and/or total occlusion), and/or (3) a combination of conditions. Study sample sizes ranged from 11 \[[@CR40]\] to 40 \[[@CR42]\] patients with diagnostic heterogeneity both within and across studies. Of the 10 included studies, five \[[@CR43], [@CR44], [@CR46]--[@CR48]\] used VFSS to measure swallowing outcomes with four \[[@CR39], [@CR42], [@CR45], [@CR47]\] using FEES. Other measurement methods included manometry \[[@CR40], [@CR45]\], EMG \[[@CR41]\], and accelerometry \[[@CR41]\]. When swallowing impairment was reported, two studies \[[@CR44], [@CR45]\] utilized a psychometrically validated tool (PAS), while seven used binary descriptions (e.g. presence/absence) \[[@CR39], [@CR42], [@CR43], [@CR48]\], study-specific scales \[[@CR44], [@CR46]\], or a combination of methods \[[@CR47]\]. For quantified measurements (i.e. pressures, durations, distance), all \[[@CR40], [@CR41], [@CR44], [@CR45]\] but one \[[@CR47]\] reported specific measurement metrics. Given the limitations in the primary studies, including bias risk, small sample sizes with heterogeneous patient diagnoses, and the wide range of assessment methods, the evidence is inconclusive.

Quality of the Evidence {#Sec18}
-----------------------

Risk of bias as well as study design limitations were evident across all studies likely leading to inaccurate estimates of swallowing physiology. Given the variability inherent in the included studies, we synthesized our results descriptively. All studies were case series \[[@CR39]--[@CR48]\]. Many did not report on their patient sampling methods \[[@CR39]--[@CR41], [@CR43], [@CR44], [@CR47]\] or the patient inclusion/exclusion criteria \[[@CR39], [@CR42]--[@CR44]\]. As a result, it was difficult to determine how their sample was derived rendering an inability to judge the potential effect of patient selection on study outcomes. The majority of the studies in our review were unclear in regard to their assessor blinding \[[@CR39]--[@CR42], [@CR44], [@CR45], [@CR47], [@CR48]\] and additionally, some studies \[[@CR39], [@CR43], [@CR44], [@CR48]\] did not present all outcomes. As a result, our ability to gauge the effect of assessor bias on outcomes is also limited. Despite these shortcomings, all studies \[[@CR39]--[@CR48]\] provided clear operational outcome definitions and accounted for patient attrition affording a clear understanding of the targeted outcomes for the patient sample. In addition, the two studies with lowest bias risk had only one domain ranked as unclear \[[@CR41], [@CR45]\].

Diagnoses, illness severity, tracheostomy duration, and modification duration likely play a role in swallowing outcomes. Two studies had homogeneous patient samples \[[@CR41], [@CR45]\] and of those, one reported on tracheostomy tube placement durations \[[@CR45]\]. The within- and across-study heterogeneity evident in the areas of patient diagnoses, tracheostomy tube placement durations, and other airway management practices likely played a role in the equivocal and, at times, the divergent findings of this review. This diversity, when coupled with very small sample sizes, can increase a study's risk for underpowering, calling into question whether enough data were collected in order to render a substantiated conclusion. Not only did patient diagnostic heterogeneity \[[@CR39], [@CR40], [@CR42]--[@CR44], [@CR46]--[@CR48]\] and small sample sizes \[[@CR40], [@CR41], [@CR43], [@CR44], [@CR46]--[@CR48]\] likely play a role in the outcomes, but only a few studies reported the details for patients' airway management (e.g. weaning procedure or duration of tracheostomy) \[[@CR41], [@CR42], [@CR46], [@CR48]\] or baseline swallowing measures \[[@CR42], [@CR44]--[@CR46]\], making it difficult to assess whether these variables may have influenced study outcomes. For example, within a single study \[[@CR43]\], tracheostomy tube duration ranged from eight to 546 days, with the range of all included studies from five \[[@CR44]\] to 546 days \[[@CR43]\]. Only three studies reported on the duration for which the patient was subjected to the tracheostomy modification condition \[[@CR39], [@CR44], [@CR45]\], making it difficult to determine whether time could be a factor in the study outcomes. Other factors relevant to tracheostomy weaning and the use of tracheostomy modifications include pulmonary performance data. With very few studies reporting on this specifically \[[@CR39], [@CR40], [@CR42]--[@CR48]\], only one study \[[@CR41]\] reported pulmonary variables at the time of tracheostomy modification. Given the effect of pulmonary performance on weaning in general and on research study outcomes specifically, future work should include pulmonary measures in order to provide users a framework by which to interpret and apply study findings.

In addition to limiting the ability to conduct meta-analyses, the methodological variability by which swallowing physiology was interpreted and the limited information in the primary studies regarding the tracheostomy tube itself, also impacted our ability to determine the effect of tracheostomy modifications, if any. Two studies \[[@CR44], [@CR45]\] used a psychometrically validated method of rating swallowing impairment, specifically, the PAS. Both of these studies reported functional improvement in swallowing on most conditions. The remaining seven studies \[[@CR39], [@CR42]--[@CR44], [@CR46]--[@CR48]\] defined swallowing impairment using methods and/or scales unique to their specific study. While half of these studies \[[@CR39], [@CR42], [@CR47], [@CR48]\] reported improved swallowing, whether these findings are valid or reliable is difficult to ascertain. Interestingly, all studies conducting quantitative swallowing measurements had clear directions regarding functional swallow change. Specifically, cuff deflation led to the improvement of most swallowing parameters \[[@CR41], [@CR44]\] with tracheostomy occlusion (regardless of method or type) \[[@CR40], [@CR44], [@CR45], [@CR47]\] rendered no significant measurement change. Other independent variables which have the potential to affect the swallow include tracheostomy tube type and its associated diameter, particularly when considering cuff alterations (e.g. inflation or deflation). In clinical practice, the tracheostomy tube type and size used is often dependent upon patient-specific parameters including sex, trachea size, and/or pulmonary needs. Pressures in the upper airway (e.g. in the cuff) are affected, in part, by tracheostomy tube size, the size of the patient's trachea, and volume of air in the cuff. As a result, these variables have the potential to impact swallowing biomechanics in many ways not limited to the pressures generated during the swallow. Hence, these independent variables are key to understanding the impact of tracheostomy modifications in general but more particularly in conditions where cuff volumes are altered. Of the four studies investigating cuff volume alterations \[[@CR41], [@CR44], [@CR46], [@CR48]\], only two studies reported on tracheostomy tube diameter \[[@CR44], [@CR48]\]. As a result, it is difficult to ascertain the degree to which other variants or independent variables impact swallowing outcomes. Together, this supports the use of more objective approaches to measuring swallowing in future studies, whether through psychometrically validated impairment scales or quantitative measurements along with the inclusion of relevant tracheostomy tube data.

Review Limitations {#Sec19}
------------------

Although we employed rigorous selection criteria and methodology, our review has limitations. Due to the heterogeneity across the included studies' patient diagnoses and outcomes measures, we were unable to conduct meta-analyses. The relatively few included studies, their diverse tracheostomy modification conditions, and various swallowing assessment and interpretation methods made it impossible to conclude whether specific conditions either facilitate the swallow or impair it. Future research should include (1) homogenous patient populations where disease severity and tracheostomy duration are controlled, (2) sample sizes as determined by power analyses, and (3) more rigorous methodology, specifically employing baseline measurements, psychometrically validated interpretation methods and/or quantitative measurements, and assessor blinding.

Implications for Clinical Practice and Research {#Sec20}
-----------------------------------------------

Based on the available evidence, we are unable to determine the effect of tracheostomy modifications on swallowing physiology. The majority of the studies that we identified have poor study quality and high bias risk. Given the multifactorial nature of dysphagia following tracheostomy, it is important to espouse a study design that facilitates objective comparisons while controlling for confounds. We recommend homogeneity across both patient diagnoses and airway variables or alternatively, large enough samples to support the inherent heterogeneity while providing generalizability and the opportunity for statistical testing. Primary studies should also report on the pulmonary and tracheostomy data with greater detail. This would include, but not be limited to: pulmonary performance, ventilator parameters, cuff volume measurement, tracheostomy tube size, and tracheostomy tube type. Furthermore, utilizing instrumental swallowing assessments to capture the swallow following tracheostomy modifications is prudent given the complexity of this patient population and their high rates of aspiration and silent aspiration \[[@CR39], [@CR43], [@CR44], [@CR46]\]. Following assessment completion, it is crucial to interpret these assessments ideally through psychometrically validated tools or quantitative measurements in order to maintain objectivity and facilitate within and between study comparisons. Moving forward, these steps will facilitate our understanding of the impact of tracheostomy modification on swallowing physiology thereby informing how best to remediate dysphagia following tracheostomy placement.
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